(Q38035961)

27 August 2017

title

The Shigella human challenge model (English)

1 reference

27 August 2017

C K Porter

1

1 reference

27 August 2017

N Thura

series ordinal

2

1 reference

27 August 2017

R T Ranallo

series ordinal

3

1 reference

27 August 2017

M S Riddle

series ordinal

4

1 reference

27 August 2017

publication date

21 August 2012

1 reference

Epidemiology and Infection

27 August 2017

published in

1 reference

27 August 2017

volume

141

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

223-232

1 reference

Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Studies with a New Generation of Oral Attenuated Shigella Vaccine: Escherichia coli Bearing Surface Antigens of Shigella flexneri

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Infection and musculoskeletal conditions: Reactive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Inoculum size in shigellosis and implications for expected mode of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Challenge studies of human volunteers: ethical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Post-infectious irritable bowel syndrome--a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

The ethical challenge of infection-inducing challenge experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Sociodemographic factors associated with serum anti-Shigella lipopolysaccharide antibodies and shigellosis

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

The response of man to virulent Shigella flexneri 2a

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Experimental human bacillary dysentery; polyvalent dysentery vaccine in its prevention

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812001677

7 January 2021

10.1017/S0950268812001677

Identifiers

DOI

1 reference

27 August 2017

1 reference